Why is Eli Lilly Betting Big on Orforglipron with a $1.5 Billion Inventory

Related Articles

Why is Eli Lilly Betting on Shingles Vaccines

4 months ago

Why Are Institutional Investors Still Bullish on Eli Lilly

6 months ago

Is McDonald's Betting Big on Premium with the Big Arch Burger

7 months ago

What's Driving the Bearish Options Activity in Eli Lilly

7 months ago

Category

You may also like

Stock News•1 week ago

Eli Lilly Just Announced Something Big. Here's What It Means for Investors.

Eli Lilly's weight loss drugs generated $14B in sales in the recent quarter, as the market is on track to approach $100B in a few years. The company dominates the category, with the scale of the oppor...

LLY

Share

Stock News•2 weeks ago

Lilly Slips as $6.5 Billion Plant Backs Oral GLP-1 Scale

Eli Lilly broke ground on a $6.5B Houston plant to make ingredients for its Foundayo weight-loss pill, even as LLY shares slipped. The investment scales oral GLP-1 supply but adds capital risk if dema...

Share

Stock News•1 months ago

Insurers Are Pulling Back From GLP-1 Drugs. The FDA Just Handed Eli Lilly Its Best Weapon Yet

Eli Lilly gained a specific FDA weapon as employer GLP-1 coverage collapses into 2027, potentially shifting payer negotiations for one market slice. The move could alter coverage dynamics if payers re...

GLP

Share